Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
AMC Robotics reported Q3 2026 revenue of $0.97 million, a 3.1% sequential increase driven by product sales growth. The company is prioritizing its Kyro quadruped robotic platform for security and inspection markets while remaining on track to commission its Vietnam manufacturing facility by year-end 2026.
Term
Q3 2026
“During the quarter, we sharpened our strategic focus on advancing Kyro, our quadruped robotic platform, toward commercialization, prioritizing opportunities in security, surveillance and inspection markets.”
Sean Da, Chairman of the Board and CEO of AMC Robotics
“The appointment of Dr. Ang Li as Chief Technology Officer further strengthens our ability to accelerate product development and bring more advanced autonomous capabilities to market, while continued progress at our Vietnam manufacturing facility keeps us on track towards initial trial production in early 2027.”
Sean Da, Chairman of the Board and CEO of AMC Robotics
Century Casinos announced that its financial statements for fiscal years 2024 and 2025, and the first two quarters of 2026, should no longer be relied upon due to accounting errors. The misstatement relates to the accounting for a 50% interest in Smooth Bourbon, LLC, which owns the real estate for the Nugget Casino Resort. The company expects to report at least one material weakness in its internal control over financial reporting as a result of the restatement.
DNA X, Inc. approved a substitute cash award for acting CEO and Executive Chairman Mike Mulica in lieu of an annual RSU grant due to a lack of available shares in the company's equity incentive plan. The award is valued at $50,000 worth of 'Phantom RSUs' as of November 14, 2026, and will be settled in cash upon vesting at the 2027 annual meeting or a change in control.
Cable One received a deficiency notice from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement. The company has 45 days to submit a plan to regain compliance within an 18-month cure period. Additionally, the company disclosed it missed a $10 million interest payment on its 4.00% senior notes due 2030, entering a 30-day grace period.
Greenlane Holdings appointed Peter Kampian as the chair of its Audit Committee, effective November 11, 2026. Mr. Kampian succeeds Bruce Linton, who will remain a member of the committee. This filing amends a previous report from October 2026 regarding Mr. Kampian's initial appointment to the Board of Directors.
Enova International $365M Debt Financing with Truist Bank
Enova International's subsidiary, Receivable Assets of OnDeck, LLC (RAOD), entered into a thirteenth amendment to its existing asset-backed revolving debt facility. The amendment sets the total facility commitment at approximately $365.1 million, consisting of Class A and Class B revolving loans, and extends the revolving period to November 2028 with a final maturity in November 2029.
Everus Construction Group Announces $100M Stock Buyback
Everus Construction Group's Board of Directors has authorized a new $100 million share repurchase program effective immediately. The program expires on December 15, 2029, and allows for open-market or privately negotiated transactions to return capital to shareholders. Management intends to use the authorization as a flexible tool alongside organic investments and strategic acquisitions.
Zoomcar Holdings completed the eighth closing of its private placement, issuing 100 Series A units for gross proceeds of $100,000. Each unit consists of one share of Series A Convertible Preferred Stock and a warrant to purchase 20,000 shares of common stock. The company has extended the termination date of the overall $5 million offering (plus a $5 million overallotment option) to November 30, 2026.
Primo Brands Corporation's subsidiaries priced a private placement of $700 million in 7.625% Senior Notes due 2034. The proceeds will be used to redeem $713 million of existing 6.250% Senior Notes due 2029, effectively refinancing the company's debt to extend maturities.
Macom Technology Solutions Holdings SVP, GC and Secretary Ambra R. Roth Sells $138K of Stock
Ambra R. Roth, SVP, GC and Secretary, sold 552 shares of Macom Technology Solutions Holdings, Inc. at $250.00 a share, worth $138K in total on Nov 12, 2026. Shares held after the trade: 15,114 (-3.5%).
Sadot Group Inc. reported a significant turnaround for the nine months ended September 30, 2026, with a net income of $32.2 million compared to a net loss of $14.2 million in the prior year, primarily driven by a $42.4 million gain on deconsolidation. Despite this, the company experienced a net loss of $3.0 million for the third quarter of 2026 as commodity sales fell sharply compared to the prior year's nine-month volume.
Pimco California Municipal Income Fund Insider Mohit Mittal Buys $809K of Stock
Mohit Mittal bought 100,000 shares of Pimco California Municipal Income Fund at $8.09 a share, worth $809K in total on Nov 12, 2026. Shares held after the trade: 100,000.
Sunrise Realty Trust President Robyn Tannenbaum Buys $34.2K of Stock
Robyn Tannenbaum, President, bought 5,000 shares of Sunrise Realty Trust, Inc. at $6.85 a share, worth $34.2K in total on Nov 12, 2026. Shares held after the trade: 97,429 (+5.4%).
Neostellar Capital Chairman, CEO and President Mark D. Klein Buys $994K of Stock
Mark D. Klein, Chairman, CEO and President, bought 165,000 shares of Neostellar Capital Corp. at $5.78 to $6.10 a share (average $6.02) in 3 transactions, worth $994K in total between Nov 12, 2026 and Nov 16, 2026. Shares held after the trade: 165,000 (+26.9%).
Keel Infrastructure COO Liam Daniel Wilson Buys $50.1K of Stock
Liam Daniel Wilson, COO, bought 28,942 shares of Keel Infrastructure Corp. at $1.73 a share, worth $50.1K in total on Nov 16, 2026. Shares held after the trade: 129,920 (+28.7%).
NRX Pharmaceuticals reported a net loss of $20.1 million for the nine months ended September 30, 2026, an improvement from the $29.0 million loss in the prior year period. The company significantly increased its cash position to $19.8 million through various equity offerings, while net patient service revenue grew to $3.3 million.
Blackbaud SVP and General Counsel Jon W. Olson Sells $42.3K of Stock
Jon W. Olson, SVP and General Counsel, sold 769 shares of Blackbaud Inc at $55.00 a share, worth $42.3K in total on Nov 12, 2026. Shares held after the trade: 40,058 (-1.9%).
BrainStorm Cell Therapeutics reported a net loss of $7.7 million for the nine months ended September 30, 2026, compared to $7.9 million in the prior year period. The company faces a significant stockholders' deficit of $12.3 million and maintains a very low cash position of $163 thousand, relying on private placements and short-term loans to fund operations.
MediaCo Holding Inc. reported a net loss of $9.3 million for the third quarter of 2026, compared to a $17.9 million loss in the prior year period. Net revenues decreased to $28.6 million from $35.4 million year-over-year, while the company's total liabilities increased slightly to $249.1 million as of September 30, 2026.
Swarmer, Inc. reported a significant increase in net loss to $21.1 million for the nine months ended September 30, 2026, compared to $5.7 million in the prior year, primarily driven by a surge in operating expenses following its initial public offering. Despite the loss, the company strengthened its liquidity position, ending the period with $37.3 million in cash and cash equivalents.
Okmin Resources reported a net loss of $122,493 for the quarter ended September 30, 2026, compared to a loss of $73,430 in the prior year period. The company's financial position remains strained with a working capital deficit of $776,920 and a significant impairment charge of $53,872 taken on its oil and gas properties during the quarter.
Iron Dome Acquisition I Corp. reported net income of $1,087,694 for the quarter ended September 30, 2026, primarily driven by $1,408,474 in interest income from its Trust Account. As a shell company, its primary activities involved completing its initial public offering and managing $159,850,245 in cash held in trust for a future business combination.
AgEagle Aerial Systems reported a significant decline in nine-month revenue from $9.82 million in 2025 to $5.97 million in 2026, alongside a net loss of $21.78 million. The company's cash position decreased from $29.86 million at year-end 2025 to $10.16 million as of September 30, 2026, driven by increased operating expenses and unrealized losses on investments.
Target Group Inc. reported a significant revenue increase to $4.27 million for the nine months ended September 30, 2026, compared to $3.15 million in the prior year. Despite higher gross profits, the company realized a net loss of $958,449 for the period, contributing to a total stockholders' deficiency of $8.83 million.
KRAKacquisition Corp reported a net loss of $3,020,297 for the nine months ended September 30, 2026, primarily driven by $11.36 million in general and administrative expenses. As a blank check company, it successfully completed its Initial Public Offering in January 2026, resulting in $352,953,916 held in a Trust Account for a future business combination.
For the nine months ended September 30, 2026, 20/20 Biolabs, Inc. reported a net loss of $5.06 million on revenues of $1.46 million, compared to a net loss of $2.43 million on revenues of $1.51 million in the prior year period. The company experienced a significant increase in operating expenses, primarily driven by sales, general, and administrative costs, and underwent a major capital restructuring involving the conversion of multiple preferred stock series into common stock.
Creative Media & Community Trust Corp reported a net loss attributable to common stockholders of $64.8 million for the nine months ended September 30, 2026, compared to a $43.9 million loss in the prior year period. The company experienced significant non-cash charges, including a $7.97 million real estate impairment and $22.4 million in preferred stock redemptions, while total revenues slightly decreased to $86.5 million.
Marker Therapeutics, Inc. reported financial results for the quarter ended September 30, 2026, highlighting continued progress in its clinical-stage cell therapy pipeline. The company maintained a net loss as it invests in R&D, with sufficient cash reserves to support operations into the following year.